- Report
- October 2023
- 96 Pages
Global
From €3500EUR$4,239USD£3,123GBP
- Report
- July 2023
- 94 Pages
Global
From €3500EUR$4,239USD£3,123GBP
- Report
- July 2023
- 87 Pages
Global
From €3500EUR$4,239USD£3,123GBP
- Report
- May 2023
- 83 Pages
Global
From €3500EUR$4,239USD£3,123GBP
- Report
- March 2024
- 92 Pages
Global
From €3500EUR$4,239USD£3,123GBP
- Report
- February 2024
- 95 Pages
Global
From €3500EUR$4,239USD£3,123GBP
- Report
- July 2023
- 98 Pages
Global
From €3500EUR$4,239USD£3,123GBP
- Report
- July 2023
- 89 Pages
Global
From €3500EUR$4,239USD£3,123GBP
- Report
- October 2023
- 100 Pages
Africa
From €885EUR$1,000USD£763GBP
€1769EUR$2,000USD£1,525GBP
- Report
- October 2023
- 80 Pages
Russia
From €663EUR$750USD£572GBP
€1327EUR$1,500USD£1,144GBP
- Report
- October 2023
- 80 Pages
Poland
From €663EUR$750USD£572GBP
€1327EUR$1,500USD£1,144GBP
- Report
- April 2024
- 132 Pages
Global
From €840EUR$950USD£724GBP

The Prefilled Syringe market is a subset of the Infusions and Injectables market, which includes a variety of medical products used to deliver drugs and other substances directly into the body. Prefilled syringes are pre-filled with a specific dose of medication, eliminating the need for manual filling and reducing the risk of contamination. They are used in a variety of medical settings, including hospitals, clinics, and home care.
Prefilled syringes offer a number of advantages over traditional syringes, including improved accuracy, convenience, and safety. They are also more cost-effective than traditional syringes, as they require less time and labor to prepare.
The Prefilled Syringe market is highly competitive, with a number of major players offering a wide range of products. Some of the leading companies in the market include Becton Dickinson, Baxter, Pfizer, Novartis, and Sanofi. Show Less Read more